Clinical trial · Interventional
Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications
Effect of Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications in Pediatric Hematology and Oncology Patients
NCT05769452CI-TRIAL-00064732nexivacompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Peripheral intravenous catheters (PIVCs) can be used frequently in pediatric hematology oncology patients. There are different types of PIVCs as open and closed. There are studies on adults using the closed IV catheter system, which is a type of PICK. However, no study was found in the literature in which the closed IV catheter system was used in the pediatric population.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Catheter Complications | — | UNRESOLVED | — |
| Catheter Leakage | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| closed IV catheter system (BD Nexiva™) | Device | — | UNRESOLVED |
| open IV catheter (BD Insyte™ Autoguard™) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- BD Nexiva™
- description
- The intervention group was given a closed IV catheter system called BD Nexiva™.
- interventionNames
- Device: closed IV catheter system (BD Nexiva™)
- type
- EXPERIMENTAL
- label
- BD Insyte™ Autoguard™
- description
- The control group received an open IV catheter called BD Insyte™ Autoguard™.
- interventionNames
- Device: open IV catheter (BD Insyte™ Autoguard™)
Primary outcomes (2)
- measure
- catheter indwelling time
- timeFrame
- during the catheterization
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: * Age range of pediatric patients is between 1-12 * Obtaining an informed consent form from the child patient and parent * Child patient receiving intravenous therapy Exclusion Criteria: * port or central venous catheter in the pediatric patient
References
Publications (1)
- DERIVEDOzalp Gerceker G, Yildirim BG, Onal A, Oren H, Olgun HN, Bektas M. The effect of the closed intravenous catheter system on first insertion success, indwelling time, and complications in pediatric hematology and oncology patients: A randomized controlled study. Eur J Oncol Nurs. 2023 Dec;67:102430. doi: 10.1016/j.ejon.2023.102430. Epub 2023 Oct 7. PMID 37879193